GE HealthCare Technologies Inc. Share Price

Equities

GEHC

US36266G1076

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 08:10:15 01/05/2024 pm IST 5-day change 1st Jan Change
77.74 USD +1.97% Intraday chart for GE HealthCare Technologies Inc. -10.45% +0.43%
Sales 2024 * 20.21B 1,688B Sales 2025 * 21.24B 1,774B Capitalization 34.79B 2,905B
Net income 2024 * 1.86B 155B Net income 2025 * 2.12B 177B EV / Sales 2024 * 1.97 x
Net Debt 2024 * 4.97B 415B Net Debt 2025 * 3.06B 255B EV / Sales 2025 * 1.78 x
P/E ratio 2024 *
18.8 x
P/E ratio 2025 *
16.5 x
Employees 51,000
Yield 2024 *
0.08%
Yield 2025 *
0.25%
Free-Float 93.07%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.99%
1 week-10.45%
Current month+1.86%
1 month-13.26%
3 months+4.45%
6 months+13.73%
Current year+0.43%
More quotes
1 week
76.08
Extreme 76.08
89.18
1 month
76.08
Extreme 76.08
90.84
Current year
71.31
Extreme 71.31
94.50
1 year
62.35
Extreme 62.35
94.50
3 years
53.00
Extreme 53
94.50
5 years
53.00
Extreme 53
94.50
10 years
53.00
Extreme 53
94.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 14/22/14
Director of Finance/CFO 51 01/23/01
Chief Tech/Sci/R&D Officer - 01/22/01
Members of the board TitleAgeSince
Director/Board Member 65 14/22/14
Chief Executive Officer 59 14/22/14
Chairman 60 03/23/03
More insiders
Date Price Change Volume
01/24/01 77.63 +1.82% 1 004 185
30/24/30 76.24 -14.28% 14,433,617
29/24/29 88.94 +3.13% 4,352,997
26/24/26 86.24 +0.34% 1,790,728
25/24/25 85.95 -0.89% 1,363,051

Delayed Quote Nasdaq, May 01, 2024 at 07:55 pm IST

More quotes
GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. It develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment portfolio is comprised of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment is comprised of two business lines: contrast media and molecular imaging.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
76.24 USD
Average target price
94.86 USD
Spread / Average Target
+24.43%
Consensus